Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ SPECTRUM PHARMACEUTICALS, INC.
01/20Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Co..
BU
01/06SPECTRUM PHARMACEUTICALS : Announces New Strategic Investment by Hanmi Pharmaceutical - Fo..
PU
01/06SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
BU
01/04Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
BU
2021SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
2021Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
BU
2021SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2021Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
BU
2021Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summi..
BU
2021Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
BU
2021Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
PU
2021SPECTRUM PHARMA : Q3 Earnings Snapshot
AQ
2021Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
BU
2021Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Cor..
BU
2021SHAREHOLDER ALERT : Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Mis..
BU
2021AACR-NTI-EROTC VIRTUAL INTERNATIONAL : Pan-ErbB inhibition enhances activity of KRASG12C i..
PU
2021SPECTRUM PHARMACEUTICALS : Announces Presentation of Poziotinib in Combination with KRASG1..
BU
2021SHAREHOLDER ALERT : Robbins LLP Reminds Investors that Spectrum Pharmaceuticals, Inc. (SPP..
BU
2021SPECTRUM PHARMACEUTICALS : to Participate in 2021 Cantor Virtual Global Healthcare Confere..
BU
2021ESMO CONGRESS 2021 : Efficacy and Safety of Poziotinib in Treatment-naïve NSCLC Harboring ..
PU
2021SPECTRUM PHARMACEUTICALS : Presents Late Breaker Oral Presentation of Poziotinib Data in F..
BU
2021SPECTRUM PHARMACEUTICALS : Announces Late-Breaking Oral Presentation of Data for Poziotini..
BU
2021SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
2021SHAREHOLDER ALERT : Robbins LLP Announces that Spectrum Pharmaceuticals, Inc. (SPPI) is Be..
BU
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Spectrum Pharmaceuticals, In..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharma..
BU
2021SPECTRUM PHARMA : Q2 Earnings Snapshot
AQ
2021SPECTRUM PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and..
AQ
2021SPECTRUM PHARMACEUTICALS : The company is requesting a meeting with the FDA to clarify the..
PU
2021SPECTRUM PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Corporate Upd..
BU
2021SPECTRUM ALERT : Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, In..
BU
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spect..
PR
2021(SPPI) ALERT : Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Inv..
PR
2021SPECTRUM PHARMACEUTICALS : Receives Complete Response Letter from FDA for ROLONTIS« (eflap..
BU
2021SPECTRUM PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results and Provide Cor..
BU
2021SPECTRUM PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders, Financ..
AQ
20212021 ASCO ANNUAL MEETING : CNS activity of poziotinib in NSCLC with exon 20 insertion muta..
PU
2021SPECTRUM PHARMACEUTICALS : Presents Poziotinib Data in Patients with Brain Metastases from..
BU
2021SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
AQ
2021SPECTRUM PHARMACEUTICALS : Letter from Deloitte & Touche LLP addressed to the Securities E..
PU
2021SPECTRUM PHARMACEUTICALS INC : Changes in Registrant's Certifying Accountant, Financial St..
AQ
2021SPECTRUM PHARMACEUTICALS : Announces That the ROLONTIS« (eflapegrastim) Pre-Approval Inspe..
BU
2021SPECTRUM PHARMACEUTICALS : to Present Data for Poziotinib in Patients with Brain Metastase..
BU
2021SPECTRUM PHARMACEUTICALS : to Participate in Two Upcoming Investor Conferences in June
BU
2021SPECTRUM PHARMA : Q1 Earnings Snapshot
AQ
2021SPECTRUM PHARMACEUTICALS : Reports First Quarter 2021 Financial Results and Corporate Upda..
BU
2021NEUTROPENIA PIPELINE : Emerging Therapies and Key pharma players involved by DelveInsight ..
AQ
2021SPECTRUM PHARMACEUTICALS : to Report First Quarter 2021 Financial Results and Provide Corp..
BU
2021SPECTRUM PHARMACEUTICALS : Poziotinib administered twice daily improves safety and tolerab..
PU
2021SPECTRUM PHARMACEUTICALS : Presents Additional Twice Daily Dosing Data for Poziotinib at t..
BU
2021SPECTRUM PHARMACEUTICALS : Presentations at the Upcoming AACR Virtual Meeting 2021 to Incl..
BU
2021SPECTRUM PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and..
AQ
2021SPECTRUM PHARMA : Q4 Earnings Snapshot
AQ
2021SPECTRUM PHARMACEUTICALS : Reports Fourth Quarter 2020 and Full Year 2020 Financial Result..
BU
2021SPECTRUM PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2020 Financial Results a..
AQ
2021SPECTRUM PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2020 Financial Results a..
BU
2021SPECTRUM PHARMACEUTICALS : Provides Update on ROLONTIS« (eflapegrastim) Pre-Approval Inspe..
BU
2021SPECTRUM PHARMACEUTICALS : FDA Grants Fast Track Designation to Spectrum Pharmaceuticals P..
AQ
2021SPECTRUM PHARMACEUTICALS : FDA Grants Fast Track Designation to Spectrum Pharmaceuticals' ..
BU
202138TH ANNUAL MIAMI BREAST CANCER CONF : Interim safety evaluation of same-day dosing of efl..
PU
2021ESMO TAT VIRTUAL CONGRESS 2021 : Safety, tolerability and preliminary efficacy of poziotin..
PU
2021SPECTRUM PHARMACEUTICALS : Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT..
BU
2021SPECTRUM PHARMACEUTICALS : Announces Poster Presentation at Upcoming Miami Breast Cancer C..
BU
2021SPECTRUM PHARMACEUTICALS : Announces Two Presentations at Upcoming ESMO TAT Virtual Congre..
BU
2021SPECTRUM PHARMACEUTICALS : to Participate in Guggenheim Healthcare Talks 2021 Oncology Day
BU
2021SPECTRUM PHARMACEUTICALS : Announces Two Oral Presentations at Upcoming IASLC 2020 World C..
AQ
2021SPECTRUM PHARMACEUTICALS : Announces Two Oral Presentations at Upcoming IASLC 2020 World C..
BU
2021SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
2021SPECTRUM PHARMACEUTICALS : to Participate in Three Upcoming Investor Conferences in Januar..
BU
2020SABCS : Open-label, phase 1 study to evaluate duration of severe neutropenia after same-da..
PU
2020SABCS : Pooled efficacy analysis from two phase 3 studies in patients receiving eflapegras..
PU
2020SABCS : A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast can..
PU
2020SPECTRUM PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on SPECTRUM PHARMACEUTICALS, INC.
03/09/22